Ophthalmology Search
Ophthalmology Ophthalmology
blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.
  1. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  2. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Blepharitis - limited revision. AAO. www.aao.org/ppp. 2011.
  3. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern® Guidelines. Blepharitis. AAO. http://www.aao.org/preferred-practice-pattern/blepharitis-ppp.
  4. American Optometric Association Original Consensus Panel. Optometric clinical practice guideline. Care of the patient with ocular surface disorders. American Optometric Association. St. Louis, MO; 2011.
  5. Fort G, Mikolich D. Blepharitis. Ferri: Ferri’s clinical advisor. 1st: Mosby, an imprint of Elsevier; 2012.
  6. Ganatra J, Goldstein M. Blepharitis. In: Yanoff M, Duker JS, et al. Ophthalmology. 3rd ed: Mosby, an imprint of Elsevier; 2009.
  7. Shtein RM. Blepharitis. UpToDate. http://uptodate.com. 2015 Mar.
Editor's Recommendations
Most Read Articles
IVR injection frequency tied to inferior subfield thickness in diabetic macular oedema
27 Apr 2017
The baseline inferior subfield retinal thickness may predict the frequency of treatment for diabetic macular oedema (DME) during the first year in eyes administered pro re nata (PRN) intravitreal ranibizumab (IVR) injections, a new study shows.